Bone health in MEN1 syndrome is still poorly investigated, as demonstrated by the fact that two of the most important and well-known national MEN1 databases, the GENEM in France [26] and the Dutch MEN1 Study Group (DMSG) in The Netherlands [27], are both missing the collection and analysis of bone mass parameters. This evidence concerns the gene MEN1 and multiple endocrine neoplasia type 1.